Vaxinia MAST Trial:
47 heavily pre-treated patients have been dosed to date (24 April 2024), of which 40 patients are evaluable meaning they received at least their first scan at day 42
• Nearly half of the evaluable patients (48%) have remained on treatment for more than 3 months, representing significant disease control; 3 monotherapy patients have remained on treatment for over 200 days
perhaps a new update soon ?
onCARlytics OASIS Trial:
Preliminary early combination data are expected in the fourth quarter of 2024.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Vaxinia MAST Trial:47 heavily pre-treated patients have been...
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.2¢ |
Change
0.001(0.98%) |
Mkt cap ! $383.0M |
Open | High | Low | Value | Volume |
5.2¢ | 5.2¢ | 5.1¢ | $571.5K | 11.16M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 5007776 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 5998796 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
32 | 5007776 | 0.051 |
99 | 7423752 | 0.050 |
33 | 3491018 | 0.049 |
27 | 1518248 | 0.048 |
10 | 2424265 | 0.047 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 5998796 | 29 |
0.053 | 918852 | 17 |
0.054 | 1440622 | 11 |
0.055 | 1524380 | 13 |
0.056 | 1168939 | 12 |
Last trade - 12.09pm 13/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |